Albert Labs Archives

Psychedelics News

Albert Labs

Industry

2 May 2023

Albert Labs Receives Acceptance of 35 Patent Claims for Manufacturing Technology

Albert Labs International Corp. (CSE: ABRT) (the "Company" or "Albert Labs"), a fully-integrated biopharmaceutical drug discovery company bringing innovative medicines to patients with unmet mental health needs, is pleased to...

By Microdose NewsDesk

Law & Politics

24 May 2022

Health Canada Continues to Support Psychedelic Medicine

Albert Labs receives Health Canada License and joins the list of Special Access Programme (SAP) providers, and Numinus is approved to treat the first patient in Quebec in partnership with...

By Freddie Earlam

Industry

18 May 2022

Albert Labs Granted Health Canada Licence

Albert Labs has been issued a Health Canada License enabling the possession, production, and delivery of psilocybin and other psychoactive controlled substances...

By Microdose NewsDesk

Press Releases

26 Apr 2022

Albert Labs Announces the Addition of Renowned Scientists

Professor Robert Britton and Dr Ricardo Jorge Dinis-Oliveira bring drug development and pharmacology/toxicological expertise to Albert Labs's board....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

15 Mar 2022

Is the UK Becoming a Global Center for Psychedelic Medicine?

With innovative companies and industry-leading research, as well as an increasingly favorable regulatory environment, it seems the United Kingdom is indeed positioning itself as a leading center for the psychedelic...

By Freddie Earlam

Finance

10 Mar 2022

Albert Labs Begins Trading on the CSE

The psychedelic medicine industry has a new player....

By Jason Najum

Press Releases

6 Jan 2022

MHRA Guidance for Regulatory Decision-Making Supports Albert Labs’ Licensing Pathway

MHRA Guidance on the use of Real-World Data in Clinical Studies for Regulatory Decision-Making Supports Albert Labs' Licensing Pathway NEWS PROVIDED BY Albert Labs Inc....

By Microdose

Press Releases

5 Mar 2021

MEC signs RTO definitive agreement to acquire Albert Labs, a European psychedelic drug researcher & developer

Albert Labs leverages Real-World Evidence (RWE) studies across Europe to accelerate access to its proprietary psilocybin-based therapy for patients with urgent, unmet needs....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result